Home/Filings/4/0001127602-24-014199
4//SEC Filing

Keeney Adam 4

Accession 0001127602-24-014199

CIK 0000875045other

Filed

May 2, 8:00 PM ET

Accepted

May 3, 8:00 PM ET

Size

8.3 KB

Accession

0001127602-24-014199

Insider Transaction Report

Form 4
Period: 2024-05-01
Keeney Adam
Head of Corporate Development
Transactions
  • Exercise/Conversion

    Common Stock

    2024-05-01+938938 total
  • Exercise/Conversion

    Restricted Stock Unit

    2024-05-019381,877 total
    Exercise: $0.00Exp: 2026-05-01Common Stock (938 underlying)
  • Tax Payment

    Common Stock

    2024-05-01$216.13/sh276$59,652662 total
Footnotes (1)
  • [F1]The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of May 1, 2023.

Issuer

BIOGEN INC.

CIK 0000875045

Entity typeother

Related Parties

1
  • filerCIK 0001973607

Filing Metadata

Form type
4
Filed
May 2, 8:00 PM ET
Accepted
May 3, 8:00 PM ET
Size
8.3 KB